StockNews.AI
ARCT
StockNews.AI
119 days

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025

1. Arcturus will release Q1 2025 financial results on May 12. 2. A conference call will follow, potentially revealing key insights.

Earnings
+3.94%Current Return
VS
+1.59%S&P 500
$12.1704/22 04:15 PM EDTEvent Start
$12.6504/23 11:01 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

The announcement suggests no immediate changes to growth prospects. Historically, earnings calls impact stocks variably based on results.

How important is it?

Quarterly results and guidance could significantly impact share price volatility. Upcoming results can lead to investor reassessment of future growth based on performance metrics.

Why Short Term?

The next quarter results and conference call are upcoming, influencing short-term market reactions. Previous earnings announcements show fluctuations in ARCT’s stock prices around these events.

Related Companies

MRNAPFENVAX
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that it will release its financial results for the quarter ended March 31, 2025 after the market close on Monday, May 12 and will also host a conference call and webcast at 4:30 pm Eastern Time on May 12, 2025.

Related News